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ABSTRACT
Isolation techniques developed by the HHMI and the SEA-PHAGES program were used
to obtain a bacteriophage from a mixture of loamy clay soil. The sample was retrieved from a
forest edge in central Kentucky. The isolate produced large lytic plaques on a lawn of the
bacterium Mycobacterium smegmatis. The bacteriophage was purified, amplified, and analyzed
using restriction digest analysis with visualization by gel electrophoresis. Restriction digest
analysis suggests the virus belongs to a group known as “A”. Mycobacteriophages are placed
into distinct groups based on DNA sequences comparison. The next step in the procedure will
be to document with an electron micrographic image. The virus will then be sequenced, so the
genome can be annotated. The virus will be able to be further characterized in its cluster during
the annotation process. Future studies include testing rates of infectivity of at various
temperatures. It is my goal that these studies will allow the determination of a novel
bacteriophage.

INTRODUCTION
Viruses are more abundant than any other organism on Earth, including bacteria. For
every type of organism such as animals, plants, bacteria, and fungi there is at least one virus to
infect the cell. The most abundant type of virus is a bacteriophage (1). A bacteriophage infects
bacterial cells. Even though viruses are more common than any other organism, they are not
considered to be alive because in order for a virus to reproduce it must be inside a host cell.
Viruses are not able to replicate outside of a host cell, and therefore are not considered to be
living. A virus consists of some type of genetic material, DNA or RNA, and some kind of protein
coat. Viruses have adapted many different ways to infect host cells, so they can reproduce and
infect other cells. Many viruses have a protein coat that has the correct surface proteins to bind to
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the surface receptors on the host cell. The virus can also mimic another cell in the host, this is if
the cell is eukaryotic, that interacts with the cell the virus wants to infect. Another way a virus
successfully infects the host cell is to enclose itself in a lipid membrane from the host cell that it
infected previously. When the virus is able to do this it is virtually undetectable by the host cell.
Viruses must have the correct proteins exposed if they want to infect a host cell. If the surface
receptors on the host cell and virus do not match, the virus will not be able to infect the host cell
because the virus will not be able to bind to the host cell. This is why viruses can only attack
certain host cells and not every type of cell that exists.
The Howard Hughes Medical Institute (HHMI) is very interested in research that relates
to healthcare. HHMI collaborated with the University of Pittsburgh to make a program to that
would help get high school students interested in science (2). HHMI called the program SEAPHAGES which stands for Science Education Alliance Phage Hunters Advancing Genomics and
Evolutionary Science (2). The purpose of the program is to find viruses in the soil that can infect
Mycobacterium smegmatis. HHMI has a goal of finding a virus that can infect Mycobacterium
tuberculosis because there are strains of tuberculosis that are becoming antibiotic resistant, and it
is a growing problem (2). They can accomplish this through the SEA-PHAGES program because
Mycobacterium smegmatis is in the same family of bacteria as Mycobacterium tuberculosis.
The goal of this research is to test if there are differences in the rate of virus infectivity at
various temperatures. In order to accomplish this, a Mycobacterium virus is isolated from soil.
The infectivity rate of the virus is then tested at 37⁰C and 30⁰C. The hypothesis for the
experiment is that there will be a difference of the rate of infectivity at these temperatures. The
thought is that the difference will occur because different surface proteins will be expressed at
different temperatures.
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METHODS
Methods were adapted from Phagesdb.org. (3)

Soil Collection
Soil is collected from Quail Chase Golf Course in Louisville, Kentucky in three different
locations on the course. Three 50 mL conical tubes are used to collect soil from each location
totaling nine conical tubes. Each 50 mL tube has about 50 grams of soil.

Soil Screening
After the soil is collected, 10 grams of soil is mixed with 50 mL of phage buffer containing
500 μL of 1mM CaCl2 and 5 mL of Mycobacterium smegmatis. The mixture is incubated at
37⁰C with shaking at 225 rpm for 48 hours.

Testing for Virus
Once the soil has shaken for two days in the incubator, it is time to test to see if there is virus
in the sample. This can be done in two different ways. The first way is to perform a spot test,
which is the quickest way to see if there is phage in the sample. In this test 500 μL of
Mycobacterium smegmatis are mixed with 4.5 mL of top agar, pipetted onto a 7H10 plate
with cycloheximide (CHX) and carbenicillin (CB). The top agar is allowed to solidify for
approximately 10 minutes. Next, 10 μL of the sample are gently pipetted onto the plate. It is
best to draw a grid on the plate to avoid confusion if plating different samples on the same
plate. The other method of testing for phage involves using top agar and freshly grown
Mycobacterium smegmatis. With this test, 500 μL of M. smegmatis are incubated with 50 μL
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of the sample (which hopefully contains virus) for at least 20 minutes in a small test tube.
After 20 minutes 4.5 mL of top agar containing 1mM CaCl2 is mixed with the sample by a
pipette totaling 5 mL. This is then gently pipetted onto a 7H10 plate containing
cycloheximide (CHX) and carbenicillin (CB). Next, wait approximately 10 minutes for the
top agar to solidify before turning the plate upside down to place in the incubator. The plate
is allowed to grow for two days in an incubator at 37⁰C. A negative control is used with each
of these methods, and it can be phage buffer or water.

Virus Purification
The next step is to purify the virus in the sample to make sure that there is just one virus. In
order to accomplish this, serial dilutions of the sample must be made. A plaque is picked
from the plate that is isolated, so it is known that there is only type of virus from this point
on. From this, the plaque is added to 100 μL of phage buffer with 1mM CaCl2. The serial
dilutions then take place with 10 μL of the mixture being added to 90 μL of phage buffer.
This is the 10-1 dilution. This is repeated to the 10-4 dilution. These dilutions are then plated
on 7H10 plates with CHX and CB in the same manner as the second method for testing for
virus. The plates are incubated at 37⁰C for two days. Three rounds of this purification are
necessary to make sure that there is only one virus.

Testing the Rate of Infectivity
Once a pure sample of virus has been obtained, the infectivity rate can be tested at 37⁰C,
which is the optimum temperature for M. smegmatis to grow, and 30⁰C. The virus is tested at
each temperature. This method uses the same procedure outlined in testing for virus. Any
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differences will be visualized by looking at the plates after 48 hours of growth. A picture of
each plate is taken to record the differences.

High Titer Lysate
Once the virus is purified a high titer lysate can be made to increase the concentration of the
virus. This will help to obtain a high concentration of DNA from the virus when the DNA is
extracted. The concentration of the high titer lysate needs to be at least 108 PFU/mL. PFU
stands for plaque forming units. The high titer lysate is made by calculating the current
concentration of the virus when it makes a webbing pattern on the plate. The plate will be
mostly clear of bacteria, and it will have multiple overlapping plaques. This means it has
gone through enough rounds of infection to have enough virus to be able to collect the virus.
When the concentration of the current virus is known, the correct amount will be mixed with
Mycobacterium smegmatis and top agar with 1 mM CaCl2. Three hundred milliliters of this
will be made, with 5 mL being placed on each plate. This will total 60 plates. The plates are
then grown for 48 hours. Next, the plates need to be checked to make sure all of them contain
the webbing pattern. After this, 5 mL of phage buffer with 1 mM CaCl2 will be added to each
plate. The plates will then sit for about 4 hours with occasional gentle swirling of the plates,
or the plates can be placed in a cold room overnight. This allows the virus to be transferred to
the phage buffer. When the phage buffer has had enough time to absorb the virus, the plates
are slightly tilted to bring the liquid phage buffer with the virus to one side of the plate. The
liquid is then collected using a pipette and transferred to a 50 mL conical tube. This is
repeated for all of the plates. The conical tubes containing the high titer lysate are then placed
in a centrifugation machine for 15 minutes at 3000 rpm to remove any bacterial or agar
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debris. Next, the centrifuged lysate is filtered using a vacuum into a new 50 mL conical tube.
When the filtering is complete, the resulting liquid is the high titer lysate. The high titer
lysate now has to be tested to see which concentration of the virus will cause the webbing
pattern to appear on the plate. This done through serial dilutions of the virus that ranges from
the 10-1 dilution to 10-10 dilution.

FIGURE 1: This picture shows an example of the webbing pattern on the plate that needs to
be reached in order to be able to perform the high titer lysate methods.
DNA Purification and Extraction
To purify and extract the DNA, add 5 mL of the high titer lysate to a 15 mL conical tube, add
62.5 µL of 1M MgCl2, and gently mix. Next add 4 µL of DNAse I (2000 U/mL) and 5 µL of
RNAse A (100 mg/mL) to the mixture. Incubate at room temperature for 30 minutes after
briefly vortexing the mixture. After the incubation add 200 µL of 0.5 M EDTA, 25 µL of
Proteinase K (10 mg/mL), and 250 µL of 10% SDS. It is very important to add these reagents
and enzymes in the order that is listed. Adding them in the wrong order can cause the
extraction process to be unsuccessful. Vortex the mixture vigorously and then incubate the
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mixture for an hour at 55°C. During the hour incubation, vortex the mixture twice at 20
minute intervals. Next, get ten 1.5 mL microcentrifuge tubes, and transfer 500 µL of the
mixture into each tube. Using gloves and the chemical hood, add 500 µL of PCI or Phenol:
Chloroform: Isoamyl alcohol (25:24:1) to each microcentrifuge tube. Limit the exposure to
light for the PCI because the chemicals in the solution can become oxidized if they are
exposed to light. Once the PCI is added to each tube, invert each tube several times to ensure
enough mixing. Centrifuge the tubes for 5 minutes at 13,000 rpm at room temperature. After
this, carefully remove the top aqueous layer that is above the white interphase in the tube,
and add it to a 15 mL conical tube. It is important to make sure that none of the white
interphase or the organic layer underneath are mixed with the aqueous layer because this will
cause there to be phenol contamination and the DNA extraction will have to be repeated. The
next step is to precipitate the DNA. To do this add 5 mL of 95% ethanol and 250 µL of 3M
sodium acetate solution to the conical tube. Next, pipette equal amounts into 1.5 mL
microcentrifuge tubes, and place on ice for 5 minutes. A precipitate will form. Centrifuge for
10 minutes at 13,000 rpm at room temperature. Carefully decant the tubes as so not to lose
the pellets that are in the bottom of the tubes. Now, add 500 µL of 70% ethanol to wash the
pellet. Centrifuge for 10 minutes at 13,000 rpm at room temperature. Decant the tubes and
again be careful to not lose the pellet of DNA that has formed. Allow the pellets to air dry for
10 – 20 minutes. Add about 50 µL of deionized water to the pellet. Incubate the tubes for 10
minutes at 37°C to make sure the pellet is completely dissolved. Store the extracted DNA at
4°C for short term storage, but store the DNA at -20°C for long term storage.
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Measuring the Concentration of the DNA
The concentration of the DNA is measured by using a nanodrop spectrophotometer. This
machine only requires 2 µL of extracted DNA to be used. The machine is cleaned and
blanked with sterile deionized water. The concentration is then measured. After the
concentration is measured the machine is again cleaned with sterile deionized water.

Restriction Enzyme Digest with Visualization by Gel Electrophoresis
Once the concentration of the DNA is determined, a restriction enzyme digest can be
performed. The purpose of the restriction enzyme digest is to see if the extracted viral DNA
will be cut anywhere with various restriction enzymes. The restriction enzymes used in this
study are BamHI, ClaI, EcoRI, HaeIII, and HindIII. These are the five standard restriction
digest enzymes used to characterize viral DNA. The volume for the restriction digest is 15
µL. This means that the concentration of the DNA will determine the amount of some of the
reagents that are used for the restriction digest. Obtain five microcentrifuge tubes. Add x µL
of DNA, 1.5 µL of 10X buffer, 1.5 µL of 10X BSA, x µL of sterile deionized water, and 0.5
µL of the restriction enzyme. This needs to be repeated for every enzyme. It is very
important to add these in the correct order because the restriction digest will not work if these
are added at the wrong times. As soon as the enzyme is added, the microcentrifuge tubes
need to be placed in an incubator at 37⁰C for 1 hour.
While the incubation is taking place, the gel for the visualization of the enzymes needs to be
made. Make a 0.7% agarose gel using TAE as the buffer for the gel. To make a small gel
weigh 0.35 g of agarose in an Erlenmeyer flask, add 50 mL of 1X TAE buffer, and
microwave for 1 minute with a paper towel covering. When the flask as cooled off enough to
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be warm to the touch, add 2 µL of ethidium bromide to the mixture. Then pour this gently
into the casting tray for the gel, and place the comb to form the wells. Allow this to
completely solidify.
When the restriction digest is finished, add 2 µL of a loading dye to the digest in each tube.
Pipette the total amount of the mixture, 17 µL into the corresponding well on the gel. Make
sure to add a molecular weight marker to be able to measure the size of the DNA bands that
will form on the gel.
Run the gel for 15 minutes at 100 volts, and then turn the voltage down to 25 volts and let the
gel run for another hour and 45 minutes. This allows the bands to move slowly for good
separation on the gel.
When the gel is finished running, take a picture of the gel with UV light to visualize the
bands formed from the restriction digest of the viral DNA. This is done by allowing the
exposure time for the picture to be five seconds while the UV light is on. Be sure to wear the
proper safety eyewear, as UV light can damage the eyes and skin.

Liquid Culture and Plating
In order to be able to perform all of the above methods, Mycobacterium smegmatis must be
kept alive through liquid culture and plating. Liquid 7H9 broth with growth nutrients is used
to keep liquid cultures of the bacteria alive. The bacteria is also plated onto to 7H10 plates to
keep another form of pure bacteria. Both of these cultures are stored at 4⁰C.
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RESULTS AND DISCUSSION
Isolation of Virus
The first major result is actually isolating the virus to be studied. This is done by
purifying the virus by using serial dilutions. It is known the virus is pure once the plaques
forming on the plates are all the same size. This is the only way to determine purity in the
lab without taking electron microscope pictures of the virus to see if it is the same. It can
be very clearly seen with the plaques whether or not the plaques are the same size on the
plates, and this is why isolating the virus can be determined by looking at the plaques that
form on the plate of bacteria.

FIGURE 2: The picture of the plate on the left shows what a plate looks like before any
purification takes place. There are plaques on this plate that are multiple sizes which
indicates that they are different viruses. More purification of these viruses will need to be
done. The picture on the right shows a plate that has gone through two rounds of virus
purification. This can be seen because most of the plaques on the plate are the same size,
but there are still a few plaques that are smaller. This plate just needs to go through one
more round of purification to have an isolated virus.
Restriction Enzyme Digest
The restriction enzyme digest with visualization by using gel electrophoresis shows
where the restriction enzymes that are used cut the viral DNA. The gel shows that the
only restriction enzyme to cut the viral DNA is the restriction enzyme HaeIII. This
suggests that the virus can be classified in the Cluster A family of mycobacterium viruses
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because this cluster consists of viruses whose DNA only cuts at HaeIII (4). This is
important because it helps to give an idea on the type of virus that has been isolated. The
DNA of the virus will need to be sequenced in order to characterize the virus further.

FIGURE 3: This shows the results of the restriction enzyme digest of the viral DNA
with BamHI, ClaI, EcoRI, HaeIII, and HindIII. The only enzyme to cut the viral DNA is
HaeIII. This known from comparing the uncut DNA in Lane 2 to Lane 6 where HaeIII is
used. The DNA fragment that is cut in Lane 6 is estimated to be 500 base pairs from the
molecular marker used in Lane 9. The molecular marker in Lane 9 is a 500 base pair
marker, meaning the smallest measurement is 500 base pairs and it increases in
increments of 500 base pairs.
Rate of Infectivity at Various Temperatures
At 37⁰C and 30⁰C, there is not a difference in the infectivity rate at the 10-6 dilution of
the virus. However, at the 10-7 dilution there is a difference between the infectivity rate at
37⁰C and 30⁰C. At this dilution of the virus, the plaques that form on the plate are smaller
at 30⁰C than they are at 37⁰C. This could be due to the possibility of there being different
surface receptors expressed on the bacteria or the virus at various temperatures. There is a
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difference in the infectivity rate at 37⁰C and 30⁰C, but the difference is also dependent on
the concentration of the virus. Further research needs to be done to see why the
concentration plays a role along with the temperature. More studies also need to done to
measure the types of surface receptors on the bacteria and virus to see if this is affecting
the infectivity rate.

FIGURE 4: The picture on the left shows the bacteria and virus grown at 37⁰C with the
virus at the 10-6 dilution. The picture of the plate on the right shows the bacteria and virus
grown at 30⁰C with the virus at the 10-6 dilution. There is not a difference in plaque size
at these temperatures or the 10-6 dilution of the virus.
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FIGURE 5: The picture of the plate on the left shows the bacteria and virus grown at
37⁰C with the virus at the 10-7 dilution. The picture of the plate on the right shows the
bacteria and virus grown at 30⁰C with the virus at the 10-7 dilution. There is a difference
in the plaque size between the two plates. The plaques on the plate on the left are much
larger than the plaques of the plate on the right. This suggests that temperature plays a
role in the infectivity rate of the isolated virus.
Future Research
Future research for studying the isolated virus includes taking an electron microscope
picture of the virus to be able to visualize an individual virus instead of just seeing the
clearing on the plate of bacteria of a group of viruses. Visualizing the virus will allow for
there to be a better idea on exactly how the virus can infect the bacterial cell. The genome
of the virus also needs to be sequenced to be able to annotate the genome. Annotating the
genome will be essential in understanding the virus because knowing what genes the
virus has will be helpful in determining how the virus can infect the bacterial cell. Also,
knowing what genes the virus is made up will allow for comparison with other
Mycobacterium virus genomes.
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IMPLICATIONS
There are many positive impacts on healthcare that can come from this research. The first
is having the opportunity to potentially find viruses that can infect bacteria that has become
antibiotic resistant to multiple antibiotics. The goal of this research is to find viruses that will
infect Mycobacterium smegmatis, but the overall purpose of the research for HHMI is to see if
any of these viruses will infect Mycobacterium tuberculosis that has become antibiotic resistant
(2). This is why this research is so imperative. It could eventually save many lives if a virus is
found that can also infect and kill Mycobacterium tuberculosis. There are many places in the
world where tuberculosis is still major problem in the healthcare field, and there are many people
with cases of antibiotic resistant tuberculosis. If a virus can be found that can kill the bacteria, it
will be able to help many people that would otherwise die from the disease.
There are already examples today of viruses being used to kill antibiotic resistant
bacteria. One example is a new study that has been published about Pseudomonas aeruginosa
with chronic lung infections (5). The study focuses on chronic lung infections such as cystic
fibrosis. With this disease it is much more difficult for the body to fight off lung infections. The
other problem is that many strains of Pseudomonas aeruginosa are becoming resistant to
multiple antibiotics (5). This study has found a virus that can infect the bacteria and kill it. This a
tremendous improvement for healthcare for individuals that are suffering from chronic lung
infections. The virus is inhaled through a nasal spray so the virus can get to the patients lungs
(5). The virus is able to kill the Pseudomonas aeruginosa bacteria which would otherwise
potentially kill the person with the infection. This is known as phage therapy.
Phage therapy is now and will continue to be an important part of healthcare research
because it is the future. There are many types of bacteria that are becoming antibiotic resistant to
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multiple antibiotics. The world is coming to the point where alternatives to antibiotics need to be
found, and phage therapy is one of the alternatives that has been proven to work.
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